Citadel Advisors »

Anebulo Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Anebulo Pharmaceuticals (ANEB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Anebulo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Anebulo Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anebulo Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $25k 24k 1.01
2025-06-30 $36k 25k 1.44
2025-03-31 $15k 11k 1.30

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Anebulo Pharmaceuticals

22NW
Nantahala Capital Management
Mangrove Partners
Vanguard Group
Geode Capital Management
Rangeley Capital
Renaissance Technologies
Citadel Advisors
BlackRock
Northern Trust
Ikarian Capital
State Street Corporation
Tower Research Capital
UBS Group

View all funds holding Anebulo Pharmaceuticals